2018-19 Section 7-Neoplastic and Inflammatory Diseases of the Head and Neck eBook

Introduction The Home Study Course is designed to provide relevant and timely clinical information for physicians in training and current practitioners in otolaryngology - head and neck surgery. The course, spanning four sections, allows participants the opportunity to explore current and cutting- edge perspectives within each of the core specialty areas of otolaryngology. The Selected Recent Material represents primary fundamentals, evidence-based research, and state of the art technologies in neoplastic and inflammatory diseases of the head and neck. The scientific literature included in this activity forms the basis of the assessment examination. The number and length of articles selected are limited by editorial production schedules and copyright permission issues and should not be considered an exhaustive compilation of knowledge on Neoplastic and Inflammatory Diseases of the Head and Neck. The Additional Reference Material is provided as an educational supplement to guide individual learning. This material is not included in the course examination and reprints are not provided. Needs Assessment AAO-HNSF’s education activities are designed to improve healthcare provider competence through lifelong learning. The Foundation focuses its education activities on the needs of providers within the specialized scope of practice of otolaryngologists. Emphasis is placed on practice gaps and education needs identified within eight subspecialties. The Home Study Course selects content that addresses these gaps and needs within all subspecialties. Target Audience The primary audience for this activity is physicians and physicians-in-training who specialize in otolaryngology-head and neck surgery. Outcomes Objectives The participant who has successfully completed this section should be able to: 1. Explain the extent the effect the number of positive lymph nodes has on patients with parotid malignancies. 2. Describe factors that influence disease free survival in patients with submandibular gland salivary cancer. 3. Discuss the current clinical trials available for patients with head and neck melanoma. 4. Define the current uses and outcomes of de-intensified treatment for patients with oropharyngeal squamous cell carcinoma 5. Describe the rational for and the effects of the recent change in nomenclature from encapsulated follicular variant of papillary thyroid carcinoma to neoplasm with papillary-like nuclear features. 6. Summarize the recent changes in the staging of Head and Neck cancer patients found in the \AJCC 8th edition. 7. Review common predictors of complications for Head and Neck Cancer patients treated with free flap reconstruction. 8. Develop a treatment strategy for patients with deep neck space abscesses. 9. Discuss the outcomes of clinical trials using immunotherapeutic agents for recurrent and metastatic head and neck cancer.